CLINICAL_TRIALS
research
· 2025-07-25
Clinical Trial Update: External Hypofractionated Radiotherapy With Simultaneous Integrated Boost in Early Breast Cancer Patients [Phase 2]
Summary
A Phase 2 clinical trial is evaluating external hypofractionated radiotherapy with a simultaneous integrated boost for early breast cancer; the study is current…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Regina Elena Cancer Institute | Conditions: Breast Neoplasms, Breast Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING